Vineet Agrawal, M.D., Ph.D., received the Pulmonary Hypertension Association’s 2020 Aldrighetti Research Award for Young Investigators. Dr. Agrawal is a physician-scientist and instructor of medicine at Vanderbilt University Medical Center.
The award will support Dr. Agrawal’s research on reversing the destruction of lung vessels from pulmonary arterial hypertension (PAH) that lead to high blood pressure and right heart failure.
“Dr. Agrawal’s research could lead to a new treatment for PAH that seeks to reverse the lung vessel damage that occurs with PAH and possibly lead to a cure,” says Elizabeth Joseloff, Ph.D., PHA’s vice president of quality care and research.
The Aldrighetti award supports the career development of junior researchers who study PAH.
The two-year grant is supported by Janssen Pharmaceuticals, a division of Johnson & Johnson, through a partnership with the Pulmonary Hypertension Association (PHA). The award funds new research projects that could lead to new PAH therapies.
